Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.

PubWeight™: 2.84‹?› | Rank: Top 1%

🔗 View Article (PMID 16490846)

Published in Arch Dermatol on February 01, 2006

Authors

Brigitte A B Essers1, Carmen D Dirksen, Fred H M Nieman, Nicole W J Smeets, Gertrude A M Krekels, Martin H Prins, H A Martino Neumann

Author Affiliations

1: Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, The Netherlands. bes@kemta.azm.nl

Associated clinical trials:

Presurgical Evaluation of Skin Cancers Using HIFU | NCT03457766

Articles citing this

Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med (2013) 4.59

Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol (2012) 2.49

Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg (2011) 1.10

Pre-surgical high resolution ultrasound of facial basal cell carcinoma: correlation with histology. Cancer Imaging (2008) 1.00

Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol (2006) 0.92

Properly selected skin cancer treatments are very effective. J Invest Dermatol (2013) 0.89

Management of cutaneous tumors with mohs micrographic surgery. Semin Plast Surg (2008) 0.83

Needs assessment for Mohs micrographic surgery. Dermatol Clin (2012) 0.81

Extramammary paget disease: minimal surgical therapy. Ann Dermatol (2013) 0.79

5 years review of periocular basal cell carcinoma and proposed follow-up protocol. Eye (Lond) (2012) 0.79

Determining the value of surgical therapies for basal cell carcinoma. Arch Dermatol (2006) 0.75

Response to Rogers et al. J Invest Dermatol (2013) 0.75

Cost-effectiveness of surgical excision versus Mohs micrographic surgery for nonmelanoma skin cancer: A retrospective cohort study. J Res Med Sci (2016) 0.75

A reliable frozen section technique for basal cell carcinomas of the head and neck. Plast Surg (Oakv) (2014) 0.75

Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis. J Am Acad Dermatol (2015) 0.75

The contribution of health services research to improved dermatologic care. J Invest Dermatol (2011) 0.75

Articles by these authors

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86

Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med (2010) 9.92

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med (2013) 7.76

The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol (2003) 7.54

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med (2004) 5.68

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet (2007) 5.41

Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA (2006) 4.75

Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol (2008) 4.60

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med (2004) 4.52

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2005) 4.46

Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med (2009) 4.27

Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med (2004) 3.74

Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med (2007) 3.64

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood (2002) 3.59

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ (2006) 3.58

Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med (2002) 3.51

Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet (2004) 3.50

An association between atherosclerosis and venous thrombosis. N Engl J Med (2003) 3.39

Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation (2012) 2.95

Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens (2004) 2.71

Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol (2010) 2.59

Integrated multidisciplinary diagnostic approach for dementia care: randomised controlled trial. Br J Psychiatry (2008) 2.45

Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study. BMJ (2012) 2.38

Comparing the diagnostic performance of 2 clinical decision rules to rule out deep vein thrombosis in primary care patients. Ann Fam Med (2011) 2.34

The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis. Arch Intern Med (2003) 2.33

Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review. Ann Intern Med (2003) 2.33

The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol (2005) 2.31

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology (2005) 2.30

Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. Lancet (2011) 2.24

Safely ruling out deep venous thrombosis in primary care. Ann Intern Med (2009) 2.16

Delayed wound healing after three different treatments for widespread actinic keratosis on the atrophic bald scalp. Dermatol Surg (2003) 2.04

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood (2009) 1.93

In unselected patients, elective single embryo transfer prevents all multiples, but results in significantly lower pregnancy rates compared with double embryo transfer: a randomized controlled trial. Hum Reprod (2005) 1.90

Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2006) 1.84

Extended prophylaxis of venous thromboembolism with idraparinux. N Engl J Med (2007) 1.84

Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med (2003) 1.83

A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg (2002) 1.79

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. Blood (2008) 1.70

Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace (2012) 1.67

Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens (2007) 1.66

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J (2008) 1.64

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. Blood (2011) 1.63

Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg (2005) 1.60

The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace (2010) 1.59

Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood (2002) 1.59

Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg (2010) 1.56

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database Syst Rev (2014) 1.52

Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates. Ther Drug Monit (2006) 1.51

Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med (2010) 1.50

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation (2010) 1.50

Does fast-track treatment lead to a decrease of intensive care unit and hospital length of stay in coronary artery bypass patients? A meta-regression of randomized clinical trials. Crit Care Med (2006) 1.49

Clinical and echocardiographic correlates of intra-atrial conduction delay. Europace (2011) 1.45

Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes (2010) 1.44

Economic evaluation of deep anterior lamellar keratoplasty versus penetrating keratoplasty in The Netherlands. Am J Ophthalmol (2011) 1.44

Renal artery stenosis: cost-effectiveness of diagnosis and treatment. Radiology (2007) 1.43

Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial. Transfusion (2011) 1.43

Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J (2007) 1.42

Economic evaluation of endothelial keratoplasty techniques and penetrating keratoplasty in the Netherlands. Am J Ophthalmol (2012) 1.40

Non-ablative fractional resurfacing in combination with topical tretinoin cream as a field treatment modality for multiple actinic keratosis: a pilot study and a review of other field treatment modalities. J Dermatolog Treat (2012) 1.38

Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med (2004) 1.35

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care (2011) 1.34

A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure. J Clin Epidemiol (2009) 1.34

Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J (2012) 1.30

Guidelines were developed for data collection from medical records for use in retrospective analyses. J Clin Epidemiol (2005) 1.20

Low body mass index, anaemia and poor perinatal outcome in a rural hospital in eastern Sudan. J Trop Pediatr (2007) 1.18

Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Platelets (2006) 1.17

Oral lichen planus in childhood. Pediatr Dermatol (2005) 1.16

Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism. Haematologica (2002) 1.16

Index event bias-a numerical example. J Clin Epidemiol (2013) 1.15

ABO blood group system and placental malaria in an area of unstable malaria transmission in eastern Sudan. Malar J (2007) 1.14

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments. Health Qual Life Outcomes (2007) 1.14

Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg (2012) 1.13

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev (2010) 1.12

Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis. Patient Prefer Adherence (2013) 1.11

Patients' preferences for osteoporosis drug treatment: a discrete-choice experiment. Arthritis Res Ther (2014) 1.11

Endovascular aneurysm repair is superior to open surgery for ruptured abdominal aortic aneurysms in EVAR-suitable patients. J Vasc Surg (2010) 1.10

Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med (2002) 1.09

Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. Br J Psychiatry (2008) 1.08

Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis. Thromb Haemost (2013) 1.07

An evidence-based review of prognostic factors for glaucomatous visual field progression. Ophthalmology (2012) 1.07

Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol (2011) 1.06

Ankle brachial index measurement in primary care: are we doing it right? Br J Gen Pract (2009) 1.06

The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg (2009) 1.05

Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg (2004) 1.05

Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer. BMC Cancer (2010) 1.04

Physical activity and asthma: a systematic review and meta-analysis. PLoS One (2012) 1.03

Thrombin generation in patients after acute deep-vein thrombosis. Thromb Haemost (2008) 1.02

Predictors of inappropriate hospital stay: a clinical case study. Int J Qual Health Care (2003) 1.02

Literature review on monitoring technologies and their outcomes in independently living elderly people. Disabil Rehabil Assist Technol (2014) 1.02

All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions--an observational study. BMC Health Serv Res (2006) 1.00

Changes in hospital costs after introducing an intermediate care unit: a comparative observational study. Crit Care (2008) 0.99

Fluorescence detection and diagnosis of non-melanoma skin cancer at an early stage. Lasers Surg Med (2009) 0.99

Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model. Hum Reprod (2009) 0.99

Early loss of peritubular capillaries after kidney transplantation. J Am Soc Nephrol (2011) 0.99

Willingness to accept versus willingness to pay in a discrete choice experiment. Value Health (2008) 0.98